Dot Laboratories, Inc.

San Francisco, CA · Medtech · Private

Non-invasive diagnostic test using circulating microRNA biomarkers to detect endometriosis

Claim this profile

Follows are private to you and power your alerts

Updated · dotlab.com

Sector
Medtech
Headquarters
San Francisco, CA
Total capital
$225K
Federal grants
$225K
1 award · 2019
Rank in peer group#49 of 68
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
11 pending

Capital timeline

2019FEDERAL ↑EQUITY ↓Cumulative $225K$225K
2019FEDERAL ↑EQUITY ↓Cumulative $225K$225K

Latest events

  • Federal grantHealth and Human S · Phase I · Multi-center prospective study assessing a panel of microRNAs as a non-invasive test for endometriosis$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 68 peers

Line = median

Medtech · Instrument

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 11
  • PendingMethods For Treating EndometriosisUSPTOApplication 19270400
  • PendingClassifiers For Detection Of EndometriosisUSPTOApplication 17703321
  • PendingMethods And Compositions For Assessing Rna Levels In Biological SamplesUSPTOApplication PCTUS2024039408
Show all 11 patent records
  • Methods For Treating EndometriosisJan 8, 2026 · Application 19270400Pending
  • Classifiers For Detection Of EndometriosisFeb 23, 2023 · Application 17703321Pending
  • Methods And Compositions For Assessing Rna Levels In Biological SamplesApplication PCTUS2024039408Pending
  • Models For Detection Of EndometriosisApplication 63581247Pending
  • Models For Detection Of EndometriosisApplication 63528536Pending
  • Methods And Compositions For Assessing Rna Levels In Body FluidsApplication 63528534Pending
  • Classifiers For Detection Of EndometriosisApplication PCTUS2020030284Pending
  • Methods and Compositions for Detecting and Treating EndometriosisApplication 62552365Pending
  • Methods And Compositions For Assessing Rna Levels In Biological SamplesApplication 19504699Pending
  • Artificial Intelligence Methods And Systems For Determining Endometriosis StatusApplication 19504705Pending
  • Artificial Intelligence Methods And Systems For Determining Endometriosis StatusApplication PCTUS2024039442Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .